# MYT1L

## Overview
The MYT1L gene encodes the myelin transcription factor 1-like protein, a member of the MYT family of transcription factors, which is characterized by its zinc finger domains. This protein plays a pivotal role in neural development and function by regulating gene expression to promote neuronal maturation and maintain neuronal identity. MYT1L acts as both a transcriptional activator and repressor, depending on the cellular context, and is involved in recruiting epigenetic silencers to repress non-neuronal gene programs. This function is crucial for preserving neuronal phenotypes and preventing the activation of inappropriate developmental pathways. Mutations in the MYT1L gene have been linked to various neurodevelopmental disorders, including autism spectrum disorder, intellectual disability, and attention deficit hyperactivity disorder, highlighting its clinical significance in maintaining normal neuronal activity and function (Chen2022MYT1L; Wöhr2022Myt1l; Weigel2023MYT1L).

## Structure
The MYT1L protein is a member of the MYT family of transcription factors and is characterized by its zinc finger domains, which are crucial for its function in DNA binding and gene regulation. MYT1L contains six zinc finger domains organized into clusters: one at the N-terminus, a pair upstream of the MYT1 domain, and three at the C-terminal domain. These zinc fingers form a DNA-binding pocket, with the core sequence recognized being GAAAGTT (Chen2022MYT1L; Yip2023Complex).

The N-terminal region of MYT1L is less conserved and contains a highly acidic region enriched with glutamic acid (Glu) and aspartic acid (Asp) residues, which is implicated in transcriptional activation (Chen2022MYT1L). The MYT1 and C-terminal domains are highly conserved and contain a serine/threonine-rich region (Chen2022MYT1L).

MYT1L also interacts with the Sin3L/Rpd3L histone deacetylase complex through a conserved segment known as the Sin3-interaction domain (SID), which is crucial for its role in transcriptional repression (Marcum2020The). This interaction is characterized by a moderate affinity and involves a 22-residue segment that is highly conserved among MYT family members (Marcum2020The).

## Function
The MYT1L gene encodes a transcription factor that plays a critical role in the development and function of neurons. In healthy human cells, MYT1L is involved in promoting neuronal maturation and maintaining neuronal identity by regulating gene expression. It acts as both a transcriptional activator and repressor, depending on the context, to ensure proper neuronal development (Chen2022MYT1L). MYT1L represses non-neuronal gene expression programs, thereby preserving neuronal phenotypes and preventing the activation of inappropriate developmental pathways such as myogenesis and cardiogenesis (Weigel2023MYT1L).

MYT1L is expressed in virtually all neurons and remains active throughout life, indicating its ongoing importance in maintaining neuronal function (Weigel2023MYT1L). It is involved in recruiting epigenetic silencers like SIN3/HDAC to enhance neuronal identity by repressing non-neuronal gene programs (Weigel2023MYT1L). MYT1L also plays a role in repressing anti-neurogenic pathways such as WNT and NOTCH, which are crucial for maintaining neuronal identity and ensuring proper neurogenesis (Weigel2023MYT1L). The gene's function is essential for normal neuronal activity, as its depletion can lead to significant electrophysiological alterations and autism-related phenotypes (Weigel2023MYT1L).

## Clinical Significance
Mutations in the MYT1L gene are associated with a range of neurodevelopmental disorders, including autism spectrum disorder (ASD), intellectual disability (ID), and attention deficit hyperactivity disorder (ADHD) (Wöhr2022Myt1l). These mutations can lead to conditions such as obesity, behavioral disorders, and epilepsy (Prakasam2024Autism). MYT1L mutations often result in heterozygous de novo or inherited loss-of-function mutations, which disrupt cortical interneuron differentiation and maturation, affecting neuronal function (Prakasam2024Autism).

MYT1L haploinsufficiency has been linked to obesity and behavioral alterations in both human and mouse models, with symptoms including hyperactivity, aggressiveness, and sleep problems (Wöhr2022Myt1l; Weigel2023MYT1L). In mice, MYT1L deficiency leads to increased neuronal network activity and behavioral changes relevant to ASD, such as increased locomotion and social deficits (Weigel2023MYT1L).

MYT1L mutations are also implicated in autosomal dominant mental retardation-39 (MRD39), characterized by intellectual disability, developmental delay, and obesity (Windheuser2020Nine). The gene's role in repressing non-neuronal gene programs is crucial for maintaining neuronal identity, and its dysregulation may contribute to the phenotypes observed in individuals with MYT1L mutations (Wöhr2022Myt1l).

## Interactions
MYT1L, a transcription factor involved in neural development, participates in several significant protein interactions. It interacts with the transcriptional co-repressor Sin3B, which is part of a complex that recruits histone deacetylases (HDACs) such as HDAC1 and HDAC2. This interaction is crucial for regulating neural transcription and is confirmed through yeast and mammalian two-hybrid systems (Romm2005Myt1). The central domain of MYT1L, which shares 54% amino acid identity with MYT1, is responsible for this interaction, specifically engaging with the PAH1 domain of Sin3B (Marcum2020The; Romm2005Myt1).

MYT1L's interaction with Sin3B is significant for recruiting the Sin3L/Rpd3L histone deacetylase complex, which plays a role in repressing non-neuronal genes and facilitating neuronal differentiation (Marcum2020The). The interaction domain within MYT1L, known as the Sin3-interaction domain (SID), is a conserved motif that binds to the PAH1 domain of Sin3A, utilizing a hydrophobic cleft (Marcum2020The). This interaction is essential for MYT1L's function in neural differentiation and maintaining neuronal identity (Marcum2020The).


## References


[1. (Windheuser2020Nine) Isabelle C. Windheuser, Jessica Becker, Kirsten Cremer, Hela Hundertmark, Laura M. Yates, Elisabeth Mangold, Sophia Peters, Franziska Degenhardt, Kerstin U. Ludwig, Alexander M. Zink, Davor Lessel, Tatjana Bierhals, Theresia Herget, Jessika Johannsen, Jonas Denecke, Eva Wohlleber, Tim M. Strom, Dagmar Wieczorek, Marta Bertoli, Roberto Colombo, Maja Hempel, and Hartmut Engels. Nine newly identified individuals refine the phenotype associated with myt1l mutations. American Journal of Medical Genetics Part A, 182(5):1021–1031, February 2020. URL: http://dx.doi.org/10.1002/ajmg.a.61515, doi:10.1002/ajmg.a.61515. This article has 20 citations.](https://doi.org/10.1002/ajmg.a.61515)

[2. (Wöhr2022Myt1l) Markus Wöhr, Wendy M. Fong, Justyna A. Janas, Moritz Mall, Christian Thome, Madhuri Vangipuram, Lingjun Meng, Thomas C. Südhof, and Marius Wernig. Myt1l haploinsufficiency leads to obesity and multifaceted behavioral alterations in mice. Molecular Autism, May 2022. URL: http://dx.doi.org/10.1186/s13229-022-00497-3, doi:10.1186/s13229-022-00497-3. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s13229-022-00497-3)

[3. (Marcum2020The) Ryan Dale Marcum and Ishwar Radhakrishnan. The neuronal transcription factor myt1l interacts via a conserved motif with the pah1 domain of sin3 to recruit the sin3l/rpd3l histone deacetylase complex. FEBS Letters, 594(14):2322–2330, May 2020. URL: http://dx.doi.org/10.1002/1873-3468.13811, doi:10.1002/1873-3468.13811. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/1873-3468.13811)

[4. (Yip2023Complex) Silas Yip, Kristina Calli, Ying Qiao, Brett Trost, Stephen W. Scherer, and M. E. Suzanne Lewis. Complex autism spectrum disorder in a patient with a novel de novo heterozygous myt1l variant. Genes, 14(12):2122, November 2023. URL: http://dx.doi.org/10.3390/genes14122122, doi:10.3390/genes14122122. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/genes14122122)

[5. (Romm2005Myt1) Elena Romm, Joseph A. Nielsen, Jin G. Kim, and Lynn D. Hudson. Myt1 family recruits histone deacetylase to regulate neural transcription. Journal of Neurochemistry, 93(6):1444–1453, May 2005. URL: http://dx.doi.org/10.1111/j.1471-4159.2005.03131.x, doi:10.1111/j.1471-4159.2005.03131.x. This article has 97 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1111/j.1471-4159.2005.03131.x)

6. (Prakasam2024Autism) Autism and Intellectual Disability-AssociatedMYT1LMutation Alters Human Cortical Interneuron Differentiation, Maturation, and Physiology. This article has 0 citations.

[7. (Chen2022MYT1L) Jiayang Chen, Allen Yen, Colin P. Florian, and Joseph D. Dougherty. Myt1l in the making: emerging insights on functions of a neurodevelopmental disorder gene. Translational Psychiatry, July 2022. URL: http://dx.doi.org/10.1038/s41398-022-02058-x, doi:10.1038/s41398-022-02058-x. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41398-022-02058-x)

[8. (Weigel2023MYT1L) Bettina Weigel, Jana F. Tegethoff, Sarah D. Grieder, Bryce Lim, Bhuvaneswari Nagarajan, Yu-Chao Liu, Jule Truberg, Dimitris Papageorgiou, Juan M. Adrian-Segarra, Laura K. Schmidt, Janina Kaspar, Eric Poisel, Elisa Heinzelmann, Manu Saraswat, Marleen Christ, Christian Arnold, Ignacio L. Ibarra, Joaquin Campos, Jeroen Krijgsveld, Hannah Monyer, Judith B. Zaugg, Claudio Acuna, and Moritz Mall. Myt1l haploinsufficiency in human neurons and mice causes autism-associated phenotypes that can be reversed by genetic and pharmacologic intervention. Molecular Psychiatry, 28(5):2122–2135, February 2023. URL: http://dx.doi.org/10.1038/s41380-023-01959-7, doi:10.1038/s41380-023-01959-7. This article has 10 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41380-023-01959-7)